Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,873 total articles

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
May 14, 2026
Ajmal Hussain
Press Releases

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics Global Limited announced preliminary Q1 2026 results showcasing a substantial revenue increase to $36 million, driven primarily by its IM8 brand which reported $33.8 million, reflecting 23.1% growth over Q4 2025 and nearly sixfold year-over-year growth. The company raised its full-year IM8 revenue guidance to $190 million to $210 million …

PRE
BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2
May 14, 2026
Ajmal Hussain
Press Releases

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

BranchOut Food Inc. achieved record production in March and Q2 2026, driven by a major order to the nation's second largest warehouse club retailer and expansion with the largest warehouse club retailer. The company anticipates Q2 to be a record revenue quarter fueled by these deliveries and a potential high-margin tolling partnership nearing compl…

BOF
Intuitive Machines Reports First Quarter 2026 Financial Results; Posts Record Quarterly Revenue, Gross Margin, and Positive Adjusted EBITDA along with Record Quarter-end Backlog of $1.1 Billion
May 14, 2026
Caleb Monroe
Press Releases

Intuitive Machines Reports First Quarter 2026 Financial Results; Posts Record Quarterly Revenue, Gross Margin, and Positive Adjusted EBITDA along with Record Quarter-end Backlog of $1.1 Billion

Intuitive Machines reported strong first quarter 2026 financial results, highlighted by record quarterly revenue of $186.7 million, positive adjusted EBITDA, and backlog growth driven by the $800 million acquisition of Lanteris Space Systems. The acquisitions and new contracts with NASA, U.S. Space Force, and Space Development Agency position the c…

LUNR
Agomab to Participate in Upcoming Conferences
May 14, 2026
Hana Yamamoto
Press Releases

Agomab to Participate in Upcoming Conferences

Agomab Therapeutics, a clinical-stage biopharmaceutical company specializing in fibro-inflammatory disease treatments, will participate in several prominent healthcare and investor conferences throughout 2026. The company will present preclinical data on its inhaled TGFβR1/ALK5 inhibitor aimed at treating idiopathic pulmonary fibrosis and engage in…

AGMB
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
May 14, 2026
Ajmal Hussain
Press Releases

EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer

EDAP TMS S.A. announced a letter of intent with Telix Pharmaceuticals to collaborate on clinical research and physician education combining EDAP's Focal One Robotic HIFU therapy and Telix's PSMA PET imaging products for enhanced prostate cancer treatment. This partnership aims to integrate advanced imaging and robotic therapy to optimize treatment …

EDAP
Electra Reports Q1 2026 Progress as Refinery Construction Accelerates
May 14, 2026
Avery Klein
Press Releases

Electra Reports Q1 2026 Progress as Refinery Construction Accelerates

Electra Battery Materials Corporation reported significant progress in Q1 2026 on its cobalt sulfate refinery construction project in Ontario, Canada. The company approved a $73 million construction budget, awarded key contracts, secured a strategic supply agreement with LG Energy Solution, and obtained $20 million in government funding to support …

ELBM
Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
May 14, 2026
Hana Yamamoto
Press Releases

Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Cognition Therapeutics announced receipt of a second philanthropic donation that allows the continuation of its expanded access program (EAP) providing Zervimesine (CT1812) treatment to patients with Dementia with Lewy Bodies (DLB). The EAP, launched in 2025 and currently serving 32 participants, is now extended to two years of treatment. Positive …

CGTX
Milestone Scientific Reports Financial Results for First Quarter 2026
May 14, 2026
Leila Farooq
Press Releases

Milestone Scientific Reports Financial Results for First Quarter 2026

Milestone Scientific Inc. announced its Q1 2026 financial results showing a 30% reduction in operating expenses, significantly narrowed operating loss, and stable revenue despite Middle East shipping challenges. Medical segment revenues more than doubled year-over-year. The company completed a $2.15 million financing in April 2026 to support growth…

MLSS
MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
May 14, 2026
Maya Rios
Press Releases

MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

MiNK Therapeutics has initiated a randomized Phase 2 clinical trial evaluating their off-the-shelf allogeneic invariant natural killer T (iNKT) cell therapy, agenT-797, in patients with severe acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The study, conducted in partnership with First Lviv Territorial Medical Union and sup…

MNKT
HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies
May 14, 2026
Ajmal Hussain
Press Releases

HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies

HCW Biologics announced that its immunotherapeutic candidate HCW11-040, a pembrolizumab-based fusion protein, successfully prevented bronchopulmonary dysplasia (BPD) in an animal model during IND-enabling studies. The company plans to complete these studies by late 2027 and file an IND application promptly to treat infants at high risk of BPD, a ra…

HCWB
Genie Energy Announces First Quarter 2026 Results
May 14, 2026
Derek Hwang
Press Releases

Genie Energy Announces First Quarter 2026 Results

Genie Energy Ltd. announced its Q1 2026 financial results showing record revenue growth to $142.3 million but significant declines in gross profit, operating income, and adjusted EBITDA due to margin compression and higher customer acquisition costs. The company lowered its full-year 2026 adjusted EBITDA guidance citing ongoing margin pressures and…

GNE
Fiserv Forms Strategic Collaboration with OpenAI to Bring AI to How Fiserv Serves Financial Institutions
May 14, 2026
Avery Klein
Press Releases

Fiserv Forms Strategic Collaboration with OpenAI to Bring AI to How Fiserv Serves Financial Institutions

Fiserv, a leading financial technology company, has announced a strategic collaboration with OpenAI to incorporate frontier AI technologies into its platforms serving financial institutions. The partnership focuses on building strategic AI agents, accelerating banking modernization efforts, developing banking-specific AI capabilities, and enhancing…

FISV
Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients
May 14, 2026
Priya Menon
Press Releases

Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients

Celcuity Inc., a clinical-stage biotech company, announced an expansion of its Phase 3 VIKTORIA-2 study evaluating gedatolisib for HR+/HER2- advanced breast cancer to now include endocrine-sensitive patients, alongside endocrine-resistant ones. The company also submitted a patent application for a subcutaneous version of gedatolisib to improve long…

CELC
FitLife Brands Announces First Quarter 2026 Results
May 14, 2026
Hana Yamamoto
Press Releases

FitLife Brands Announces First Quarter 2026 Results

FitLife Brands, Inc. announced first quarter 2026 financial results with total revenue rising 59% year-over-year to $25.3 million, fueled primarily by the acquisition of Irwin which contributed significantly to wholesale revenue growth. However, gross margin declined to 37.6% due to lower-margin Irwin business, and net income decreased to $1.7 mill…

FTLF
Merlin, Inc. Reports First Quarter 2026 Results
May 14, 2026
Leila Farooq
Press Releases

Merlin, Inc. Reports First Quarter 2026 Results

Merlin, Inc., an aerospace and defense technology company specializing in autonomous flight systems, reported its Q1 2026 financials following its recent public listing. Key developments include successful automated takeoffs, advancement in civil certification with FAA and New Zealand CAA, progress on a $105 million military contract for C-130J aut…

MRLN
FTI Consulting Survey: Majority of U.S. Hospital Leaders Predict Serious Financial Challenges in the Near Future
May 14, 2026
Derek Hwang
Press Releases

FTI Consulting Survey: Majority of U.S. Hospital Leaders Predict Serious Financial Challenges in the Near Future

FTI Consulting's 2026 Hospital Operations Outlook Survey reveals that 92% of US hospital leaders anticipate significant financial challenges ahead due to affordability, policy shifts, and evolving care delivery models. Key operational pressures include workforce shortages, physician recruitment difficulties, and data security concerns. Despite adva…

FCN
Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 14, 2026
Avery Klein
Press Releases

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Nuvectis Pharma, a clinical-stage biopharmaceutical company developing precision oncology medicines, announced its participation in the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026. The company will present its clinical-stage drug candidate NXP900, which is targeting SRC family kinases for cancer treatment, with Phase 1…

NVCT
Intuitive Machines to Acquire Goonhilly Earth Station and COMSAT
May 14, 2026
Leila Farooq
Press Releases

Intuitive Machines to Acquire Goonhilly Earth Station and COMSAT

Intuitive Machines, Inc. announced its definitive agreement to acquire Goonhilly Earth Station Ltd and its US-based COMSAT division. This acquisition is set to significantly enhance Intuitive Machines' integrated space-to-Earth communications network by adding 44 antennas and expanding capacity for deep space communications, data relay, and Positio…

LUNR